Professionals | Aplastic Anemia & MDS International Foundation Return to top.


Introductory image: Patients at the Las Vegas conference

Resuscitating a Dying Marrow: Emerging Concepts and Treatment Advances in Myeloid Malignancies
December 10, 2021
Omni Hotel at CNN Center
Grand Ballroom A-C, M4/Grand Ballroom Level
Atlanta, GA

Join us at Resuscitating a Dying Marrow:  Emerging Concepts and Treatment Advances in Myeloid Malignancies
Plan to attend this complimentary CME satellite symposium that provides an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with myeloid malignancies including aplastic anemia, MDS, AML, MPN and related myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.

By attending, you will be able to:

  • Summarize recent treatment advances in paroxysmal nocturnal hemoglobinuria and describe how complement inhibitors fit into management strategies.
  • Critically evaluate treatment strategies for patients with low-risk and high-risk myelodysplastic syndromes.
  • Describe how the scientific understanding of molecular advances in Ph-negative chronic myeloproliferative neoplasms has had an impact on management strategies.
  • Summarize the role of germline predisposition to myeloid malignancies and its impact on treatment strategies.
  • List the recent treatment advances for acute myeloid leukemia in older patients, detail their mode of action and safety and efficacy profiles, and define their use in clinical management strategies.
  • Summarize the challenges in assessing transplant feasibility and current transplant strategies in older MDS patients.

Who Should Attend?
The satellite symposium is designed for an international audience including medical oncologists, hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS, AML and myeloid malignancies. In addition, members of patient advocacy groups will benefit from this program. Register HERE.
This is a Friday Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute and the Aplastic Anemia and MDS International Foundation, preceding the 63rd ASH Annual Meeting and Exposition. Registration for the ASH Annual Meeting is not required to participate in this learning activity.

AAMDSIF and The Cleveland Clinic Foundation Center for Continuing Education acknowledge educational grants for partial support of this activity from:

  • Alexion
  • Apellis 
  • Ascentage
  • BioCryst 
  • Bristol Myers Squibb
  • Geron
  • Taiho 
  • Takeda 



Share with